Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-3254
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine ; day:5 ; month:9 ; year:2022 ; pages:1-15
Aids and behavior ; (5.9.2022), 1-15
- Creator
-
Edwards, Gabriel G.
Miyashita-Ochoa, Ayako
Castillo, Enrico G.
Goodman-Meza, David
Kalofonos, Ippolytos
Landovitz, Raphael J.
Leibowitz, Arleen A.
Pulsipher, Craig
El Sayed, Ed
Shoptaw, Steven
Shover, Chelsea L.
Tabajonda, Michelle
Yang, Yvonne S.
Harawa, Nina T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10461-022-03817-z
- URN
-
urn:nbn:de:101:1-2022112221182035299886
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Edwards, Gabriel G.
- Miyashita-Ochoa, Ayako
- Castillo, Enrico G.
- Goodman-Meza, David
- Kalofonos, Ippolytos
- Landovitz, Raphael J.
- Leibowitz, Arleen A.
- Pulsipher, Craig
- El Sayed, Ed
- Shoptaw, Steven
- Shover, Chelsea L.
- Tabajonda, Michelle
- Yang, Yvonne S.
- Harawa, Nina T.
- SpringerLink (Online service)
Other Objects (12)
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Psychiatry in 21st century: The road ahead
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Psychiatry in 21st century: The road ahead
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Psychiatry in 21st century: The road ahead
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia